1. |
Hospital based surveillance for Kala-azar. |
2. |
Phase IV trial of Miltefosine in the treatment of Visceral Leishmaniasis (WHO/TDR/ICMR/Zentaris) |
3. |
Multicentric, Randomized, Controlled Clinical trial to assess the safety and efficacy of injectable Paromonycin in patients with Visceral Leishmaniasis (ICMR/WHO/TDR/OneWorld Health) |
4. |
Clinico-pathological changes in Post Kala-azar Dermal Leishmaniasis (PKDL) lesions in relations to treatment and immune response. |
5. |
Immuno-phenotyping of cellular infiltrates dermal tissue and peripheral blood from post Kala -azar dermal Leishmaniasis cases. |
6. |
Reactive nitrogen and oxygen intermediate metabolism in patients with Visceral Leishmaniasis. |
7. |
Antileishmanial bacterial metabolites from the sandfly (Phlebotomus argentipes) gut microbiota – isolation, purification, characterization and their therapeutic evaluation |
8. |
Removal of bacterial and yeast contamination from Leishmania promastigotes culture by Agar plating. |
9. |
PCR based diagnosis of Visceral Leishmaniasis from suspected cases of Kala-azar in Bihar. |
10. |
Biochemical and Molecular characterization of responsive and unresponsive Kala-azar isolated of Bihar. |
11. |
Role of CD2 Antigen in T-cell signal Transduction pathway in Visceral Leishmaniasis. |
12. |
Leishmania antigen characterization for diagnosis of Visceral Leishmaniasis |
13. |
Assessment of indigenous plant extracts for leishmanicidal and immunoprophylactic activities against Leishmania donovani for the control action plan against Visceral Leishmaniasis in India. |
14. |
Identification and characterization of sibling species of Phlebotomus argentipes relevant in transmission of Kala-azar. |
15. |
Feasibility of application of remote sensing for prediction of Kala-azar epidemic in selected foci in Bihar.
|
16. |
Identification and characterisation of Leishmania donovani (promastigote) antigen of naturally and artificially infected Phlebotomus argentipes. |
17. |
Evaluation of the impact of DDT and Malathion indoor residual spraying being used in malaria and Kala-azar control programmed on the disease prevalence. (ICMR task force project) |
18. |
Social and epidemiological aspects of Visceral Leishmaniasis in Bihar, India. "Site preparation for vaccine trial". (A WHO-BHU-ICMR-RMRIMS Collaborative Project) |
19. |
Study of grass root level functionaries of Kala-azar in Bihar |
20. |
Risk factors for Indian Kala-azar in endemic areas of Bihar. |
21. |
Study of interaction of Kala-azar and HIV infection. |
22. |
Hospital based sentinel surveillance for the sero-positive cases of HIV, HbB, HbC and VDRL in Bihar (India) |
23. |
HIV screening at Voluntary Counseling and Testing Centre (VCTC) - under Bihar State AIDS control programme |
